Tenet Healthcare (NYSE:THC) Stock Price Target Lowered at Guggenheim

Tenet Healthcare (NYSE:THC) had its target price trimmed by Guggenheim from $307.00 to $306.00 in a research report sent to investors on Friday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock.

A number of other analysts have also recently weighed in on THC. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research report on Friday, October 2nd. The Goldman Sachs Group reissued a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. Piper Sandler set a $308.00 target price on shares of Tenet Healthcare in a research note on Monday, July 27th. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a report on Monday, August 10th. Finally, Truist Financial upped their price objective on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $280.16.

Tenet Healthcare Stock Up 1.0%

Shares of THC stock opened at $273.25 on Friday. The stock has a market cap of $22.00 billion, a P/E ratio of 7.92, a price-to-earnings-growth ratio of 1.03 and a beta of 1.20. Tenet Healthcare has a one year low of $157.58 and a one year high of $283.05. The stock has a fifty day moving average price of $264.85 and a 200 day moving average price of $220.34. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.58 and a quick ratio of 1.35.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, beating the consensus estimate of $4.68 by $1.96. The business had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm’s revenue was up 6.5% on a year-over-year basis. During the same period in the previous year, the business earned $3.70 EPS. Analysts predict that Tenet Healthcare will post 20.90 earnings per share for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Tammy Romo sold 4,922 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the sale, the director owned 30,784 shares of the company’s stock, valued at $8,131,593.60. This represents a 13.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director J. Robert Kerrey sold 12,010 shares of the firm’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the completion of the sale, the director owned 4,794 shares of the company’s stock, valued at $1,264,273.68. The trade was a 71.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 106,484 shares of company stock valued at $28,898,063 over the last three months. Company insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of THC. V Square Quantitative Management LLC acquired a new stake in shares of Tenet Healthcare in the third quarter valued at approximately $26,000. Mather Group LLC. grew its position in Tenet Healthcare by 126.9% in the third quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after purchasing an additional 66 shares in the last quarter. MADDEN SECURITIES Corp acquired a new stake in Tenet Healthcare in the 3rd quarter valued at $38,000. Trust Co. of Vermont acquired a new stake in Tenet Healthcare in the 2nd quarter valued at $37,000. Finally, Fortitude Family Office LLC lifted its position in Tenet Healthcare by 52.1% during the 3rd quarter. Fortitude Family Office LLC now owns 222 shares of the company’s stock worth $57,000 after buying an additional 76 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported third-quarter earnings of $6.64 per share, well above the $4.68 consensus estimate, while revenue rose 6.5% year over year to $6.28 billion versus expectations of $5.49 billion. Strong hospital performance and cost discipline drove the earnings beat. Tenet Healthcare surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Management raised its 2026 financial outlook and forecast adjusted EBITDA of $5.05 billion to $5.20 billion. Conifer transition-related items are expected to contribute to results, while improving hospital margins and higher-acuity services are strengthening the business outlook. Tenet forecasts 2026 adjusted EBITDA
• Positive Sentiment: Deutsche Bank raised its price target to $320 from $260 and maintained a Buy rating, signaling increased confidence in Tenet’s earnings momentum and valuation potential. Deutsche Bank raises Tenet price target
• Neutral Sentiment: Guggenheim modestly reduced its price target to $306 from $307 but retained a Buy rating, leaving its fundamental view constructive. Guggenheim Tenet Healthcare rating
• Negative Sentiment: Investors continue to face risks from payer pressure, uninsured patients and surgery-related headwinds. Commentary also noted that the headline earnings beat included transition-related benefits, which could make the results less representative of recurring performance. Tenet high-acuity strategy and third-quarter performance

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.